Wesat2003
•Download as PPT, PDF•
0 likes•213 views
The document summarizes a randomized trial comparing a public health approach to a standard clinical approach for delivering antiretroviral therapy in Cameroon. The trial aims to compare the increase in CD4 cell count and other outcomes between the two approaches. It describes the standard clinical approach as relying on biological exams and physicians, while the public health approach uses simplified criteria and involves other personnel like nurses. The trial design involves randomizing patients across 9 rural hospitals to receive antiretrovirals through either approach and following outcomes over 24 months. Baseline characteristics of the 459 enrolled patients are provided. Survival and treatment change outcomes over time are shown graphically. The discussion covers feasibility challenges and capacity building efforts, as well as relevance for
Report
Share
Report
Share
![Antiretroviral therapy coverage in low- and middle-income countries, December 2007 31% [27–34%] 9 700 000 [8.7–11.0 million] 2 990 000 [2.7–3.3 million] Total 7% 100 000 7 000 North Africa and the Middle East 17% 320 000 54 000 Europe and Central Asia 25% 1 700 000 420 000 East, South and South-East Asia 62% 630 000 390 000 Latin America and the Caribbean 30% 7 000 000 2 120 000 Sub-Saharan Africa Coverage Estimated need Number of people receiving ARV therapy Geographical Region](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Informing treatment decisions for women with DCIS
Date held: February 12, 2015
Presented by: Deb Davison, Genomic Health
Topics discussed:
The latest in genomic testing and its role in cancer treatment
The most recent results from Genomic Health’s second independent clinical validation study of Oncotype DX® in DCIS patients
Q&A session about the implications of this research
Awareness about Liver Cancer in Biotechnology Students_Crimson Publishers
The document discusses a study assessing awareness of liver cancer among biotechnology students. A questionnaire was developed to evaluate students' knowledge of the etiology, transmission, treatment and personal experience with liver cancer. The results showed that the postgraduate students demonstrated a high level of awareness about liver cancer, its causes as either viral, genetic or metabolic disease, and potential treatments like medicines or surgery. The study concluded that the students displayed a comprehensive understanding of liver cancer.
Precision Medicine in Oncology
Please share this webinar with anyone who may be interested!
Watch all our webinars: https://www.youtube.com/playlist?list=PL4dDQscmFYu_ezxuxnAE61hx4JlqAKXpR
Cancer care is increasingly tailored to individual patients, who can undergo genetic or biomarker testing soon after diagnosis, to determine which treatments have the best chance of shrinking or eliminating tumours.
In this webinar, a pathologist and clinical oncologist discuss:
● how they are using these new tests,
● how they communicate results and treatment options to patients and caregivers, and
● how patients can be better informed on the kinds of tests that are in development or in use across Canada
View the video: https://youtu.be/_Wai_uMQKEQ
Follow our social media accounts:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Pinterest - https://www.pinterest.com/survivornetwork
YouTube - https://www.youtube.com/user/Survivornetca
Hepatitis c guidance 2018 update aasld idsa recommendations for testing, mana...
Hepatitis c guidance 2018 update aasld idsa recommendations for testing, managing, and treating hepatitis c virus infection
Household Catastrophic Health Expenditure From Oral Potentially Malignant Dis...
Household Catastrophic Health Expenditure From Oral Potentially Malignant Dis...Institute for Clinical Research (ICR)
Household Catastrophic Health Expenditure From Oral Potentially Malignant Disorders And Oral Cancer In Public Healthcare Of Malaysia
Presentation Slides by Mr Sivaraj Raman, presented on the 14th National Conference for Clinical Research (NCCR) 2021 Dr Wu Lien Teh Youth Investigator Awards (YIA) on 19th August 2021
Following are the links for this presentation on Zenodo Repository:
Presentation Slides: https://zenodo.org/record/5348498
E-Poster: https://zenodo.org/record/5348963ВИЧ-инфекция у женщин : стратегии 3 ключевых глобальных проблем.2016.HIV In...
ВИЧ-инфекция у женщин : стратегии 3 ключевых глобальных проблем.2016.HIV Infection Among Women- Strategies to Address 3 Key Global Challenges .2016
In this downloadable slideset, Catherine Hankins, MD, PhD, FRCPC, CM, reviews current global challenges for HIV-infected women and explores methods for HIV prevention and ART delivery, particularly in resource-limited settings.
Format: Microsoft PowerPoint (.ppt)
File size: 1.03 MB
Date posted: 9/1/2016
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and BeyondUC San Diego AntiViral Research Center
Richard Garfein, PhD, MPH
Professor
Herbert Wertheim School of Public Health and Human Longevity Science
Adjunct Professor
Division of Infectious Disease and Global Public Health
Department of Medicine
University of California, San DiegoPrecision Medicine in Oncology Informatics
Precision medicine in oncology aims to provide targeted cancer treatments based on a patient's individual tumor characteristics. The presentation discusses precision oncology initiatives including NCI-MATCH clinical trials which assign cancer therapies based on a tumor's molecular abnormalities rather than location. It outlines plans to expand genomically-based cancer trials, understand and overcome treatment resistance through molecular analysis, and establish a national cancer database integrating genomic and clinical data to accelerate cancer research. Cloud computing platforms are being developed to provide researchers access to large cancer genomic and clinical datasets. The goal is to advance precision cancer treatment by incorporating individual patient genetics and biomarkers into therapeutic decision making.
Recommended
Informing treatment decisions for women with DCIS
Date held: February 12, 2015
Presented by: Deb Davison, Genomic Health
Topics discussed:
The latest in genomic testing and its role in cancer treatment
The most recent results from Genomic Health’s second independent clinical validation study of Oncotype DX® in DCIS patients
Q&A session about the implications of this research
Awareness about Liver Cancer in Biotechnology Students_Crimson Publishers
The document discusses a study assessing awareness of liver cancer among biotechnology students. A questionnaire was developed to evaluate students' knowledge of the etiology, transmission, treatment and personal experience with liver cancer. The results showed that the postgraduate students demonstrated a high level of awareness about liver cancer, its causes as either viral, genetic or metabolic disease, and potential treatments like medicines or surgery. The study concluded that the students displayed a comprehensive understanding of liver cancer.
Precision Medicine in Oncology
Please share this webinar with anyone who may be interested!
Watch all our webinars: https://www.youtube.com/playlist?list=PL4dDQscmFYu_ezxuxnAE61hx4JlqAKXpR
Cancer care is increasingly tailored to individual patients, who can undergo genetic or biomarker testing soon after diagnosis, to determine which treatments have the best chance of shrinking or eliminating tumours.
In this webinar, a pathologist and clinical oncologist discuss:
● how they are using these new tests,
● how they communicate results and treatment options to patients and caregivers, and
● how patients can be better informed on the kinds of tests that are in development or in use across Canada
View the video: https://youtu.be/_Wai_uMQKEQ
Follow our social media accounts:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Pinterest - https://www.pinterest.com/survivornetwork
YouTube - https://www.youtube.com/user/Survivornetca
Hepatitis c guidance 2018 update aasld idsa recommendations for testing, mana...
Hepatitis c guidance 2018 update aasld idsa recommendations for testing, managing, and treating hepatitis c virus infection
Household Catastrophic Health Expenditure From Oral Potentially Malignant Dis...
Household Catastrophic Health Expenditure From Oral Potentially Malignant Dis...Institute for Clinical Research (ICR)
Household Catastrophic Health Expenditure From Oral Potentially Malignant Disorders And Oral Cancer In Public Healthcare Of Malaysia
Presentation Slides by Mr Sivaraj Raman, presented on the 14th National Conference for Clinical Research (NCCR) 2021 Dr Wu Lien Teh Youth Investigator Awards (YIA) on 19th August 2021
Following are the links for this presentation on Zenodo Repository:
Presentation Slides: https://zenodo.org/record/5348498
E-Poster: https://zenodo.org/record/5348963ВИЧ-инфекция у женщин : стратегии 3 ключевых глобальных проблем.2016.HIV In...
ВИЧ-инфекция у женщин : стратегии 3 ключевых глобальных проблем.2016.HIV Infection Among Women- Strategies to Address 3 Key Global Challenges .2016
In this downloadable slideset, Catherine Hankins, MD, PhD, FRCPC, CM, reviews current global challenges for HIV-infected women and explores methods for HIV prevention and ART delivery, particularly in resource-limited settings.
Format: Microsoft PowerPoint (.ppt)
File size: 1.03 MB
Date posted: 9/1/2016
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and BeyondUC San Diego AntiViral Research Center
Richard Garfein, PhD, MPH
Professor
Herbert Wertheim School of Public Health and Human Longevity Science
Adjunct Professor
Division of Infectious Disease and Global Public Health
Department of Medicine
University of California, San DiegoPrecision Medicine in Oncology Informatics
Precision medicine in oncology aims to provide targeted cancer treatments based on a patient's individual tumor characteristics. The presentation discusses precision oncology initiatives including NCI-MATCH clinical trials which assign cancer therapies based on a tumor's molecular abnormalities rather than location. It outlines plans to expand genomically-based cancer trials, understand and overcome treatment resistance through molecular analysis, and establish a national cancer database integrating genomic and clinical data to accelerate cancer research. Cloud computing platforms are being developed to provide researchers access to large cancer genomic and clinical datasets. The goal is to advance precision cancer treatment by incorporating individual patient genetics and biomarkers into therapeutic decision making.
Ats neumonia
This document provides guidelines for the diagnosis and treatment of community-acquired pneumonia (CAP) in adults. It addresses 16 specific questions related to diagnostic testing, determining treatment location, selecting initial antibiotic therapy, and ongoing management. While some recommendations remain unchanged from 2007, new evidence has led to revised guidance for empiric treatment strategies and management decisions. The guidelines were developed using the GRADE framework to systematically review evidence and formulate recommendations.
Chapter 15 precision medicine in oncology
This document discusses precision medicine in oncology and molecular monitoring of cancer patients. It describes how molecular characterization of tumors can guide treatment decisions and help develop targeted therapies. Next-generation DNA sequencing is allowing large amounts of tumor DNA to be analyzed to identify molecular targets and guide clinical trials matching treatments to tumor mutations. Challenges include limiting sequencing to known targets, accounting for germline variants, incidental findings, and integrating sequencing results into clinical decision making. Repeated biopsies during treatment can provide insights into drug sensitivity and resistance mechanisms in individual patients.
Midterm Outcome Evaluation of Government-Led Endeavors to Eliminate Hepatitis...
Midterm Outcome Evaluation of Government-Led Endeavors to Eliminate Hepatitis...Institute for Clinical Research (ICR)
Midterm Outcome Evaluation of Government-Led Endeavors to Eliminate Hepatitis C as a Public Health Threat by 2030 in Malaysia
Presentation Slides by Mr Chan Huan Keat, presented on the 14th National Conference for Clinical Research (NCCR) 2021 Dr Wu Lien Teh Youth Investigator Awards (YIA) on 19th August 2021
Following are the links for this presentation on Zenodo Repository:
Presentation Slides: https://zenodo.org/record/5348475
E-Poster: https://zenodo.org/record/534856401.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited SettingsUC San Diego AntiViral Research Center
This presentation summarizes research on cryptococcal antigen screening and treatment in resource-limited settings. It finds that screening individuals with CD4 counts <100 cells/uL and <200 cells/uL can reduce mortality, and point-of-care tests now enable screening in primary care clinics. Studies of simplified treatment regimens show promise, such as using high-dose liposomal amphotericin B for only 1-2 weeks. Field work in Mozambique demonstrated a 7.3% prevalence of cryptococcal antigenemia through screening at two clinics, and identified opportunities to improve care through expanded screening and ambulatory treatment models.Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...Institut national du cancer
The Flu-FIT Program : An Effective Colorectal Cancer Screening Intervention
Présentation de Michael B. Potter au colloque "Recherche interventionnelle contre le cancer : Réunir chercheurs, décideurs et acteurs de terrain » - 17 et 18 novembre 2014, BnF, ParisSILS 2015 - Connecting Precision Medicine to Precision Wellness
By: Joel Dudley, Mount Sinai School of Medicine
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
Gabriel Wagner, MD
Associate Clinical Professor
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
Updates on COVID-19 Research: SECURE-IBD & IBD Partners
In this global pandemic, IBD patients and their healthcare providers from around the world share similar fears and concerns. SECURE-IBD is an international database to monitor and report on COVID-19 in IBD patients. By working across borders, we are learning how factors like age, other conditions, and IBD treatments impact COVID-19 outcomes. This slide deck also shares information about other research efforts that are ongoing to better understand the impact of COVID-19 on IBD patients.
The Foundation would like to thank AbbVie Inc., Genentech, Inc., Gilead Sciences, Inc., Janssen Biotech, Inc., Shire, and Takeda Pharmaceuticals U.S.A., Inc., sponsors of our COVID-19 materials. Additional support is provided through the Foundation’s annual giving program and individual donors.
Cancer and Nutrition NIHR infrastructure collaboration - Alan Jackson
Cancer and Nutrition NIHR infrastructure collaboration - Alan JacksonWorld Cancer Research Fund International
Slides from Alan Jackson's presentation on the Cancer and Nutrition NIHR infrastructure collaboration at Obesity, Physical Activity & Cancer: Life course influences and mechanisms02.05.21 | COVID-19 and Pregnancy
Jocelyn Keehner, MD
Infectious Disease Fellow
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
09.11.20 | Review of New Antiretrovirals
This document summarizes a presentation on new and investigational antiretrovirals given at the UC San Diego HIV & Global Health Rounds. The presentation reviewed fostemsavir, cabotegravir/rilpivirine, leronlimab, islatravir, and lenacapavir. For each drug, the presenter discussed indications, dosing, efficacy and safety data from clinical trials, resistance profiles, and potential advantages and limitations. The goal of the HIV & Global Health Rounds is to provide clinicians and researchers with the most up-to-date information on HIV, hepatitis, tuberculosis, and other infectious diseases.
Systematic review of master protocols
Critical evaluation of an article titled " Systematic review of basket trials, umbrella trials, and platform trials: A landscape analysis of master protocols"
Testing for Acute HIV and Early Initiation of ART
This document summarizes evidence from several studies on testing for acute HIV infection and initiating antiretroviral therapy (ART) on the same day as diagnosis. It discusses the optimal window for initiating ART after infection to restore immune function based on a study showing greater probability of achieving CD4 counts over 900 if starting ART within 4 months of infection. It also summarizes results from randomized controlled trials and observational studies demonstrating that rapid/same-day ART initiation improves linkage to care, ART initiation rates, and viral suppression compared to standard of care with initiation delayed by weeks or months.
Canada's path forward for rare diseases: Discovery to translation
Canada's path forward for rare diseases: Discovery to translationCanadian Organization for Rare Disorders
1. The document outlines Canada's plan for rare diseases which includes discovering genomic causes, determining disease mechanisms, and developing therapies.
2. The plan involves creating a trans-Canadian rare disease pipeline that includes rare disease gene discovery, phenotyping and mechanism studies, and therapeutic discovery and validation. This pipeline will involve over 4000 rare disease samples, 90 mechanism projects covering over 200 rare diseases.
3. The goals are to solve 56% of over 4000 rare disorders, add new genes to the known gene list, develop disease models and screening methods to identify drug targets and leads, and validate potential therapies. Several rare diseases have already seen benefits from applying this approach.SECURE-IBD Updates on COVID-19 and impact on IBD patients
As COVID-19 continues to affect individuals around the globe, we want to gain a deeper understanding of how the illness impacts IBD patients. That's why researchers created SECURE-IBD, an international pediatric and adult IBD database to monitor and report on outcomes of COVID-19 occurring in IBD patients. This slide deck provides updates on the SECURE-IBD registry as of April 15, 2020.
Factors associated with developing esophageal adenocarcinoma in Barett's esop...
Based on the study “Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett’s esophagus cohort” by Krishnamoorthi R et al published in “HHS Public Access” on 2016 July
The Continuous Update Project: Novel approach to reviewing mechanistic evide...
The Continuous Update Project: Novel approach to reviewing mechanistic evide...World Cancer Research Fund International
This document describes the Continuous Update Project, a novel approach developed by the World Cancer Research Fund to systematically review mechanistic evidence on diet, nutrition, physical activity and cancer. The approach involves conducting systematic reviews and meta-analyses of both epidemiological and mechanistic studies to make judgements on causal relationships. It emphasizes reproducibility, predefined criteria, and reviews evidence separately from making judgements. The goal is to help identify causal links between exposures and cancer outcomes.04.10.20 | Updates in HIV Prevention from CROI 2020
This document summarizes key information from an HIV & Global Health Rounds presentation on updates from the 2020 Conference on Retroviruses and Opportunistic Infections (CROI 2020). The presentation covered the global HIV epidemic, contraception and prevention, treatment as prevention, pre-exposure prophylaxis (PrEP), and HIV vaccines. Highlights included findings from the ECHO contraceptive study showing no increased HIV risk from various contraceptives, modest reductions in HIV incidence from universal test and treat trials, long-term efficacy and safety data from the DISCOVER PrEP trial, and the failure of the HVTN 702 vaccine trial to show efficacy.
The Continuous Update Project: Recent Findings on Diet, Nutrition, Physical A...
The Continuous Update Project: Recent Findings on Diet, Nutrition, Physical A...World Cancer Research Fund International
Professor Michael Leitzmann presentation on The Continuous Update Project: Recent Findings on Diet, Nutrition, Physical Activity and Cancer at FENS European Nutrition Conference, 20-23 October 2015 Berlin (Germany).Advances in Personalized Medicine and Improving the Quality of Life: The Futu...
Advances in Personalized Medicine and Improving the Quality of Life: The Futu...Cancer Treatment Centers of America
This document discusses advances in personalized cancer treatment and improving patient quality of life. It outlines goals of anti-cancer therapy including maximizing survival, treating symptoms, and improving quality of life. Studies show quality of life scores can predict survival, and improvements in physical functioning correlate with better outcomes. Targeted and precision therapies are highlighted like treatments for EGFR mutations in lung cancer and BRAF mutations in melanoma. Challenges in developing precision medicines are addressed, but new technologies are making genome sequencing cheaper and more accessible to guide individual treatment.Web pd intro_2005
This document provides an overview of the Positive Deviance (PD) approach for addressing community problems. The PD approach identifies uncommon but successful behaviors or strategies that some community members (positive deviants) are already using to find better solutions to problems than their neighbors, despite having access to the same resources. The PD process involves defining the problem, determining if any positive deviants exist, discovering their beneficial behaviors, and designing interventions for others to adopt those behaviors. The PD approach focuses on identifying internal solutions already working within a community rather than external solutions.
Se and aids community
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against developing mental illness and improve symptoms for those who already have a condition.
More Related Content
What's hot
Ats neumonia
This document provides guidelines for the diagnosis and treatment of community-acquired pneumonia (CAP) in adults. It addresses 16 specific questions related to diagnostic testing, determining treatment location, selecting initial antibiotic therapy, and ongoing management. While some recommendations remain unchanged from 2007, new evidence has led to revised guidance for empiric treatment strategies and management decisions. The guidelines were developed using the GRADE framework to systematically review evidence and formulate recommendations.
Chapter 15 precision medicine in oncology
This document discusses precision medicine in oncology and molecular monitoring of cancer patients. It describes how molecular characterization of tumors can guide treatment decisions and help develop targeted therapies. Next-generation DNA sequencing is allowing large amounts of tumor DNA to be analyzed to identify molecular targets and guide clinical trials matching treatments to tumor mutations. Challenges include limiting sequencing to known targets, accounting for germline variants, incidental findings, and integrating sequencing results into clinical decision making. Repeated biopsies during treatment can provide insights into drug sensitivity and resistance mechanisms in individual patients.
Midterm Outcome Evaluation of Government-Led Endeavors to Eliminate Hepatitis...
Midterm Outcome Evaluation of Government-Led Endeavors to Eliminate Hepatitis...Institute for Clinical Research (ICR)
Midterm Outcome Evaluation of Government-Led Endeavors to Eliminate Hepatitis C as a Public Health Threat by 2030 in Malaysia
Presentation Slides by Mr Chan Huan Keat, presented on the 14th National Conference for Clinical Research (NCCR) 2021 Dr Wu Lien Teh Youth Investigator Awards (YIA) on 19th August 2021
Following are the links for this presentation on Zenodo Repository:
Presentation Slides: https://zenodo.org/record/5348475
E-Poster: https://zenodo.org/record/534856401.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited SettingsUC San Diego AntiViral Research Center
This presentation summarizes research on cryptococcal antigen screening and treatment in resource-limited settings. It finds that screening individuals with CD4 counts <100 cells/uL and <200 cells/uL can reduce mortality, and point-of-care tests now enable screening in primary care clinics. Studies of simplified treatment regimens show promise, such as using high-dose liposomal amphotericin B for only 1-2 weeks. Field work in Mozambique demonstrated a 7.3% prevalence of cryptococcal antigenemia through screening at two clinics, and identified opportunities to improve care through expanded screening and ambulatory treatment models.Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...Institut national du cancer
The Flu-FIT Program : An Effective Colorectal Cancer Screening Intervention
Présentation de Michael B. Potter au colloque "Recherche interventionnelle contre le cancer : Réunir chercheurs, décideurs et acteurs de terrain » - 17 et 18 novembre 2014, BnF, ParisSILS 2015 - Connecting Precision Medicine to Precision Wellness
By: Joel Dudley, Mount Sinai School of Medicine
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
Gabriel Wagner, MD
Associate Clinical Professor
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
Updates on COVID-19 Research: SECURE-IBD & IBD Partners
In this global pandemic, IBD patients and their healthcare providers from around the world share similar fears and concerns. SECURE-IBD is an international database to monitor and report on COVID-19 in IBD patients. By working across borders, we are learning how factors like age, other conditions, and IBD treatments impact COVID-19 outcomes. This slide deck also shares information about other research efforts that are ongoing to better understand the impact of COVID-19 on IBD patients.
The Foundation would like to thank AbbVie Inc., Genentech, Inc., Gilead Sciences, Inc., Janssen Biotech, Inc., Shire, and Takeda Pharmaceuticals U.S.A., Inc., sponsors of our COVID-19 materials. Additional support is provided through the Foundation’s annual giving program and individual donors.
Cancer and Nutrition NIHR infrastructure collaboration - Alan Jackson
Cancer and Nutrition NIHR infrastructure collaboration - Alan JacksonWorld Cancer Research Fund International
Slides from Alan Jackson's presentation on the Cancer and Nutrition NIHR infrastructure collaboration at Obesity, Physical Activity & Cancer: Life course influences and mechanisms02.05.21 | COVID-19 and Pregnancy
Jocelyn Keehner, MD
Infectious Disease Fellow
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
09.11.20 | Review of New Antiretrovirals
This document summarizes a presentation on new and investigational antiretrovirals given at the UC San Diego HIV & Global Health Rounds. The presentation reviewed fostemsavir, cabotegravir/rilpivirine, leronlimab, islatravir, and lenacapavir. For each drug, the presenter discussed indications, dosing, efficacy and safety data from clinical trials, resistance profiles, and potential advantages and limitations. The goal of the HIV & Global Health Rounds is to provide clinicians and researchers with the most up-to-date information on HIV, hepatitis, tuberculosis, and other infectious diseases.
Systematic review of master protocols
Critical evaluation of an article titled " Systematic review of basket trials, umbrella trials, and platform trials: A landscape analysis of master protocols"
Testing for Acute HIV and Early Initiation of ART
This document summarizes evidence from several studies on testing for acute HIV infection and initiating antiretroviral therapy (ART) on the same day as diagnosis. It discusses the optimal window for initiating ART after infection to restore immune function based on a study showing greater probability of achieving CD4 counts over 900 if starting ART within 4 months of infection. It also summarizes results from randomized controlled trials and observational studies demonstrating that rapid/same-day ART initiation improves linkage to care, ART initiation rates, and viral suppression compared to standard of care with initiation delayed by weeks or months.
Canada's path forward for rare diseases: Discovery to translation
Canada's path forward for rare diseases: Discovery to translationCanadian Organization for Rare Disorders
1. The document outlines Canada's plan for rare diseases which includes discovering genomic causes, determining disease mechanisms, and developing therapies.
2. The plan involves creating a trans-Canadian rare disease pipeline that includes rare disease gene discovery, phenotyping and mechanism studies, and therapeutic discovery and validation. This pipeline will involve over 4000 rare disease samples, 90 mechanism projects covering over 200 rare diseases.
3. The goals are to solve 56% of over 4000 rare disorders, add new genes to the known gene list, develop disease models and screening methods to identify drug targets and leads, and validate potential therapies. Several rare diseases have already seen benefits from applying this approach.SECURE-IBD Updates on COVID-19 and impact on IBD patients
As COVID-19 continues to affect individuals around the globe, we want to gain a deeper understanding of how the illness impacts IBD patients. That's why researchers created SECURE-IBD, an international pediatric and adult IBD database to monitor and report on outcomes of COVID-19 occurring in IBD patients. This slide deck provides updates on the SECURE-IBD registry as of April 15, 2020.
Factors associated with developing esophageal adenocarcinoma in Barett's esop...
Based on the study “Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett’s esophagus cohort” by Krishnamoorthi R et al published in “HHS Public Access” on 2016 July
The Continuous Update Project: Novel approach to reviewing mechanistic evide...
The Continuous Update Project: Novel approach to reviewing mechanistic evide...World Cancer Research Fund International
This document describes the Continuous Update Project, a novel approach developed by the World Cancer Research Fund to systematically review mechanistic evidence on diet, nutrition, physical activity and cancer. The approach involves conducting systematic reviews and meta-analyses of both epidemiological and mechanistic studies to make judgements on causal relationships. It emphasizes reproducibility, predefined criteria, and reviews evidence separately from making judgements. The goal is to help identify causal links between exposures and cancer outcomes.04.10.20 | Updates in HIV Prevention from CROI 2020
This document summarizes key information from an HIV & Global Health Rounds presentation on updates from the 2020 Conference on Retroviruses and Opportunistic Infections (CROI 2020). The presentation covered the global HIV epidemic, contraception and prevention, treatment as prevention, pre-exposure prophylaxis (PrEP), and HIV vaccines. Highlights included findings from the ECHO contraceptive study showing no increased HIV risk from various contraceptives, modest reductions in HIV incidence from universal test and treat trials, long-term efficacy and safety data from the DISCOVER PrEP trial, and the failure of the HVTN 702 vaccine trial to show efficacy.
The Continuous Update Project: Recent Findings on Diet, Nutrition, Physical A...
The Continuous Update Project: Recent Findings on Diet, Nutrition, Physical A...World Cancer Research Fund International
Professor Michael Leitzmann presentation on The Continuous Update Project: Recent Findings on Diet, Nutrition, Physical Activity and Cancer at FENS European Nutrition Conference, 20-23 October 2015 Berlin (Germany).Advances in Personalized Medicine and Improving the Quality of Life: The Futu...
Advances in Personalized Medicine and Improving the Quality of Life: The Futu...Cancer Treatment Centers of America
This document discusses advances in personalized cancer treatment and improving patient quality of life. It outlines goals of anti-cancer therapy including maximizing survival, treating symptoms, and improving quality of life. Studies show quality of life scores can predict survival, and improvements in physical functioning correlate with better outcomes. Targeted and precision therapies are highlighted like treatments for EGFR mutations in lung cancer and BRAF mutations in melanoma. Challenges in developing precision medicines are addressed, but new technologies are making genome sequencing cheaper and more accessible to guide individual treatment.What's hot (20)
Midterm Outcome Evaluation of Government-Led Endeavors to Eliminate Hepatitis...
Midterm Outcome Evaluation of Government-Led Endeavors to Eliminate Hepatitis...
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
SILS 2015 - Connecting Precision Medicine to Precision Wellness
SILS 2015 - Connecting Precision Medicine to Precision Wellness
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
Updates on COVID-19 Research: SECURE-IBD & IBD Partners
Updates on COVID-19 Research: SECURE-IBD & IBD Partners
Cancer and Nutrition NIHR infrastructure collaboration - Alan Jackson
Cancer and Nutrition NIHR infrastructure collaboration - Alan Jackson
Canada's path forward for rare diseases: Discovery to translation
Canada's path forward for rare diseases: Discovery to translation
SECURE-IBD Updates on COVID-19 and impact on IBD patients
SECURE-IBD Updates on COVID-19 and impact on IBD patients
Factors associated with developing esophageal adenocarcinoma in Barett's esop...
Factors associated with developing esophageal adenocarcinoma in Barett's esop...
The Continuous Update Project: Novel approach to reviewing mechanistic evide...
The Continuous Update Project: Novel approach to reviewing mechanistic evide...
04.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 2020
The Continuous Update Project: Recent Findings on Diet, Nutrition, Physical A...
The Continuous Update Project: Recent Findings on Diet, Nutrition, Physical A...
Advances in Personalized Medicine and Improving the Quality of Life: The Futu...
Advances in Personalized Medicine and Improving the Quality of Life: The Futu...
Viewers also liked
Web pd intro_2005
This document provides an overview of the Positive Deviance (PD) approach for addressing community problems. The PD approach identifies uncommon but successful behaviors or strategies that some community members (positive deviants) are already using to find better solutions to problems than their neighbors, despite having access to the same resources. The PD process involves defining the problem, determining if any positive deviants exist, discovering their beneficial behaviors, and designing interventions for others to adopt those behaviors. The PD approach focuses on identifying internal solutions already working within a community rather than external solutions.
Se and aids community
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against developing mental illness and improve symptoms for those who already have a condition.
Wesat0503
This document discusses the importance of civil society consultation in developing model laws to address HIV/AIDS. It states that civil society organizations should be at the center of both developing the laws by providing input and expertise, and implementing the laws by sensitizing others and engaging with policymakers. The document also describes the consultation process between civil society and the Southern African Development Community Parliamentary Forum in drafting a model law, including a civil society meeting. It includes a civil society declaration to continue advocacy for human rights in the HIV response and adoption of the model law.
Aids se dsd
The document discusses addressing denial, stigma, and discrimination faced by people living with HIV/AIDS. It shares experiences of various organizations that have created more enabling environments through approaches like increasing openness, counseling family members, training healthcare workers, and empowering people living with HIV/AIDS. It also recommends forming a group called AAROHII to document work on stigma and discrimination and influence policies to reduce it.
Query formulation (chapter 1)
The document provides guidance on how to frame a good query for a solution exchange community. It discusses including context about the query poster's work, clearly stating the issue being faced, specifically asking a question, and providing a signature. It also covers types of queries like seeking experiences, examples, referrals, or advice. Tips are given for drafting queries that will appeal to members and generate useful responses, such as focusing on real problems and avoiding ambiguity.
The ant story.pps
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
Se aids india for se thai visioning workshop
The AIDS Community India has grown significantly since its inception in 2005. By October 2005, membership had risen to over 4,000 people and there had been over 2,500 responses to Solution Exchange action groups. The community has established several action groups and consolidated replies to address key issues. It has also worked to reduce stigma and promote universal access to treatment in accordance with India's National AIDS Policy. The community strives to translate its objectives of knowledge sharing and collective action into activities and initiatives to advance the AIDS response in India.
Viewers also liked (7)
Similar to Wesat2003
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...UC San Diego AntiViral Research Center
Hepatitis C elimination in HIV-infected men who have sex with men: reality and challenges
Edward Cachay MD, MAS
February 23rd, 2018
UCSD HIV & Global Health RoundsСовременное лечение ВИЧ: новые парадигмы в АРТ / Contemporary Management of H...
Набор слайдов c рассмотрением важных вопросов об АРТ первого ряда, арв-препаратами пролонгированного действия и схемами АРТ с двумя препаратами, акцент в публикации на роль новых стратегий.
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
This study analyzed reasons for modifications to first-line antiretroviral therapy (ART) regimens in a cohort of patients in Swaziland. The most common reasons for modification were gastrointestinal toxicities, peripheral neuropathy, and lipodystrophy related to d4T use. Patients initiating ART with lower CD4 counts or higher weight had poorer regimen durability. The findings emphasize the need to avoid toxic ART drugs, start treatment earlier, and identify patients who may require TB treatment or become pregnant.
Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...
This document discusses management of HIV in heavily treatment-experienced patients with multiclass resistance and limited treatment options. It provides an overview of the problem, including that some older patients were treated early in the HIV epidemic with less potent regimens, resulting in resistance. Younger patients may have congenital HIV and been treated long-term. Assessment of virologic failure and resistance testing are important to select an effective new regimen. Current options for active drugs in these patients include maraviroc, ibalizumab, fostemsavir, and enfuvirtide, which have novel mechanisms of action. Adherence assessment is also critical to determine if the current regimen may still be effective if taken as prescribed.
Immunological and clinical assessment of adult hiv
This document summarizes a study of HIV patients in Nigeria who switched from first-line to second-line antiretroviral treatment. The study analyzed data from 4,206 patients treated at a hospital HIV clinic between 2006-2014. It found that after several years on first-line drugs, patients generally had improved CD4 counts and clinical conditions. However, about 25% were lost to follow up, and some showed immunological failure requiring a switch to second-line protease inhibitor-based regimens. Characteristics of patients at initiation, during treatment, and at the switch point were analyzed to evaluate treatment responses and needs for improved retention in care.
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
Вопросы, связанные с АРТ первого ряда, смена арв-стратегии для пациентов с вирусной супрессией, акцентом на возрастающую роль новыхантиретровирусных стратегий.
journal.pone.0006828.PDF
This document evaluates a low-cost viral load assay called the Cavidi reverse transcriptase (RT) assay for monitoring the virologic response to antiretroviral therapy in 100 HIV-infected adults in Kenya over 48 weeks. The RT assay was compared to gold standard assays, Roche RNA PCR and Bayer bDNA. While the mean differences in viral loads between assays were small, the limits of agreement exceeded 0.5 log copies/ml, meaning the RT assay cannot be used interchangeably with the gold standards to monitor individual patients. However, the RT assay had 100% sensitivity and 95% specificity in detecting viral loads above 400 copies/ml compared to the gold standards, and 96% of patients had undetect
Cancer and Internist - Koronadal Internist Society.pdf
General internists can participate in cancer care in several ways:
1) They can conduct cancer screening tests for breast, cervical, colorectal, liver, and prostate cancers to detect cancers early.
2) They can educate patients on cancer prevention strategies like maintaining a healthy weight, being physically active, not smoking, limiting alcohol, and following dietary recommendations.
3) They can manage cancer patients in a multidisciplinary setting to provide comprehensive care involving screening, prevention, treatment, palliative care, and survivorship support.
Cancer and the General Internist
Cancer and the General Internist discusses how general internists can participate in cancer care. Key points include:
1. Cancer is a leading cause of death in the Philippines and costs of treatment are high, often leading to financial catastrophe for patients.
2. General internists can play roles in cancer screening, prevention through lifestyle counseling, and multidisciplinary care throughout the cancer continuum.
3. Filipinos actively search online for information about cancer signs, symptoms, and treatments. General internists are well-positioned to provide guidance and education to the public.
Current Controversies in Managing HIV-Infected Patients.2014
This document discusses controversies in managing HIV-infected patients. It begins with a discussion on whether all naive patients should be started on an integrase inhibitor regimen. It reviews key trials demonstrating the efficacy of integrase inhibitors in treatment-naive patients. Expert panel discussion notes some integrase inhibitors have advantages like high barriers to resistance but others have drawbacks like twice-daily dosing. The next section examines the controversy around performing anal Pap smears routinely on all HIV+ MSM, reviewing guidelines and suggested screening paradigms. The final section discusses the controversy around evaluating all HIV+ patients over 50 with DXA scans. It reviews data on bone disease prevalence and recommendations, including evaluating risk factors before obtaining scans.
Current Controversies in Managing HIV-Infected Patients.2014
This document discusses controversies around bone density screening in HIV-positive patients. It presents recommendations from guidelines that baseline bone density screening with DXA scans should be performed for all HIV-positive postmenopausal women and men aged 50 years or older. Studies show both osteopenia and osteoporosis are more common in the HIV-positive population compared to HIV-negative controls. The odds of osteoporosis are approximately 3-4 times higher for HIV patients.
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
State of the Sciences: Research Updates from the IAS Leadership
Tuesday, December 8, 2015
Johns Hopkins Bloomberg School of Public Health
02. hiv dr di indonesia
This document discusses HIV drug resistance monitoring in Indonesia. It provides background on the HIV epidemic in Indonesia, noting the first reported case in 1980 and rapid increase between 1990-2010. It describes the scale up of antiretroviral therapy (ART) starting in 2004-2005. It also discusses the establishment of the National Working Group on HIV Drug Resistance in 2005 and their key activities of monitoring early warning indicators and conducting HIV drug resistance surveys. Results of various drug resistance monitoring activities from 2004-2014 are presented, finding levels of transmitted drug resistance below 5%. Future plans for 2016-2019 include expanding early warning indicator monitoring, conducting additional drug resistance monitoring and surveys, and achieving WHO accreditation for the national HIV drug resistance genotyping
Highlights of IAS 2013.CCO Official Conference Coverage of the 7th IAS Confer...
Highlights of IAS 2013.CCO Official Conference Coverage of the 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention
Cco ias 2013_new_data
This 3-sentence summary provides the essential information from the document:
The document outlines a conference program from June 30 - July 3, 2013 in Kuala Lumpur, Malaysia called IAS 2013, which covered highlights and official coverage of HIV pathogenesis, treatment, and prevention. It includes slides on antiretroviral therapy guidelines, clinical trials of new drugs and regimens, and investigational long-acting antiretroviral agents. The
Dr. Frank Sullivan - Early diagnosis of lung cancer
The document discusses early diagnosis of lung cancer through potential screening programs utilizing low-dose CT scans and blood-based biomarkers. It describes:
1) Current poor outcomes of lung cancer diagnosed at late stages and potential for improved survival if detected earlier. A case study is presented of a patient whose cancer was found too late.
2) Ongoing research into using low-dose CT screening and blood-based biomarkers individually and together to detect lung cancer at earlier stages. Early results from a large Scottish trial combining CT and biomarkers show promising increases in operable cancers detected.
3) Key information needs and roles of primary care physicians in potential future organized lung cancer screening programs, as identified through focus groups in Ontario.
Новые данные с конференции по ВИЧ-инфекции CROI 2017/Clinical Impact of New D...
Clinical Impact of New Data From CROI 2017
Expert faculty members Joel E. Gallant, MD, MPH, and Charles B. Hicks, MD, summarize key studies from this important annual conference.
Format: Microsoft PowerPoint (.ppt)
File size: 1.25 MB
Date posted: 3/3/2017
Divina.ppt
This document summarizes a study on factors influencing clients' adherence to tuberculosis treatment under the Public-Private Mix Directly Observed Treatment Short-course (PPMD-DOTS) program in Cebu, Philippines. The study found that income level, quality of health services, and perceived social stigma were significant predictors of treatment adherence, with quality of health services most strongly influencing adherence. The study concluded that income and social stigma can help screen for adherence and that improving health service quality should be considered to promote adherence.
Benjamin Bearnot - New treatments for the infectious complications of substan...
Benjamin Bearnot - New treatments for the infectious complications of substan...Benjamin Bearnot, MD
New treatments for infectious complications of substance use disorders and barriers to implementation were discussed. The scope of substance use disorder problems was reviewed. New highly effective treatments for Hepatitis C like Harvoni and Viekira Pak were presented along with barriers like cost and side effects. New treatments for skin and soft tissue infections like dalbavancin were also discussed. Two case studies were then presented to demonstrate management of patients with these issues. Barriers to treatment included access to care, adherence, and cost. Future directions around integrating care and new treatments were proposed.Sai In Ed
The document discusses sharps associated infections (SAIs) among emergency department healthcare workers (EDHCWs). It finds that EDHCWs face high risk of SAIs due to the large volumes of high-risk patients and invasive procedures in the ED. Compliance with universal precautions among EDHCWs is poor. The document recommends a three-pronged approach of education, enforcement of safety policies, and engineering controls like safety devices to help prevent SAIs among EDHCWs.
Similar to Wesat2003 (20)
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...
Современное лечение ВИЧ: новые парадигмы в АРТ / Contemporary Management of H...
Современное лечение ВИЧ: новые парадигмы в АРТ / Contemporary Management of H...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...
Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...
Immunological and clinical assessment of adult hiv
Immunological and clinical assessment of adult hiv
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
Cancer and Internist - Koronadal Internist Society.pdf
Cancer and Internist - Koronadal Internist Society.pdf
Current Controversies in Managing HIV-Infected Patients.2014
Current Controversies in Managing HIV-Infected Patients.2014
Current Controversies in Managing HIV-Infected Patients.2014
Current Controversies in Managing HIV-Infected Patients.2014
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Highlights of IAS 2013.CCO Official Conference Coverage of the 7th IAS Confer...
Highlights of IAS 2013.CCO Official Conference Coverage of the 7th IAS Confer...
Dr. Frank Sullivan - Early diagnosis of lung cancer
Dr. Frank Sullivan - Early diagnosis of lung cancer
Новые данные с конференции по ВИЧ-инфекции CROI 2017/Clinical Impact of New D...
Новые данные с конференции по ВИЧ-инфекции CROI 2017/Clinical Impact of New D...
Benjamin Bearnot - New treatments for the infectious complications of substan...
Benjamin Bearnot - New treatments for the infectious complications of substan...
More from Mohamed Rafique
Live a carefree life!
Champion Care Homes is a residential facility for senior citizens located in Kerala, India. It was established to address the growing demand for senior living facilities driven by an aging population and changing family structures. The 40-unit facility offers independent and assisted living options with amenities and 24/7 care and services. Champion Care Homes aims to set standards for quality senior care in India through its services, technology, and medical expertise.
Query formulation
This document provides guidance on framing good queries for an online knowledge sharing community called EMPHASIS. It discusses including context, clearly stating the issue, writing a concise question, and adding a signature. The context gives background on the query poster and why the question is being asked. The issue describes the on-the-ground challenges being faced. The question is direct and focuses responses. Tips include speaking to the query poster to clarify details and drafting the query yourself. The goal is to present issues compellingly to engage community members in responding.
Osy vulnerability stakeholder analysis
This document presents data on the languages spoken in 13 Indian states and union territories based on a vulnerability analysis of 153 individuals. The majority spoke Hindi (22) in Uttar Pradesh, while Tamil (12) was most commonly spoken in Tamilnadu, and Oriya (3) was most spoken in Orissa. A total of 153 individuals across 13 regions were analyzed for primary language.
Ning addphotos
This document provides instructions for adding photos to a Ning account in 3 steps: enter the email and password on the main page, click photos and then add photos, drag and drop photos into the right box and click next to upload them so they are visible with other photos on the photos page.
Knowledge sharing & communication mechanisms
This document outlines knowledge sharing and communication mechanisms for a regional collaboration project. It proposes using online tools like Ning, Google Docs, Skype and email forums for collaboration, communication and knowledge management. Key aspects include setting up an integrated website and social networking site, facilitating online discussions, consolidating replies and developing archives, resources and translated documents that are accessible to all project partners. Implementation will begin with designating a facilitator, developing participation guidelines and launching the online platform by January 2010.
Kathmandu presentation nabesh
Mobile populations from Nepal, Bangladesh, and India's eastern states migrate within and across India for work. [Nepali migrants] travel set routes, working as artisans or laborers in cities. They face exploitation, low wages, abuse by police and lack access to healthcare or education. [Bangladeshi migrants] include families and some women forced into sex work. [Eastern Indian migrants] work in factories and homes, facing discrimination and unequal treatment. All groups are highly vulnerable with minimal legal protections and support systems.
How to add photos in ning
To upload photos from Flickr to Ning and save storage space:
1) Sign in to your Ning account and go to the Photos section of your main page.
2) Click "Add Photos" and select the option to add photos from Flickr.
3) Authorize Ning to access your Flickr photos and select the photos you want to import.
For emphasis ci update 271010
The document discusses the EMPHASIS program in India which aims to support migrants traveling between India, Nepal, and Bangladesh. It provides details on:
- The routes the program will cover between the three countries
- The first year activities which will focus on building knowledge and understanding program assumptions
- Key processes completed in the first year like staff recruitment, workshops, and contracting NGO partners
- Current activities by NGO partners like mapping destinations and collecting data on migrant populations
- Recommendations for the program including getting team input, liaising with other initiatives, and considering a transit-destination paradigm.
Final presentation for bangladesh annual review meeting
This document provides details from a mapping exercise of the Nepali migrant population in Delhi, India. It summarizes the locations and sub-locations where Nepali migrants live, including population estimates. It also describes patterns of mobility, occupations, health issues, awareness levels, stigma and discrimination faced. Case studies are provided of vulnerable individuals, including details of their lives, health issues, and lack of access to services. Challenges of the mapping exercise and learnings are also summarized.
Estimates of mobile population111
This document provides estimates of mobile populations crossing borders between India and Nepal/Bangladesh based on mapping and line listing data collected at transit sites.
Key findings include:
- Over 12,000 Nepalis from Accham and Kanchanpur districts cross into India through two transit points in Nepal each year, with around 8,500 heading to Delhi and Mumbai.
- In Delhi, the mobile Nepali population is estimated between 24,000-30,000, with around 3,650 meeting criteria to be considered an "impact population".
- In Mumbai, previous projects have reached around 40,000 Nepalis, suggesting an impact population of around 3,360 for this project if it focuses on certain source
Emphasis pres-sep 5-2010
The EMPHASIS program is a 5-year initiative funded by the Big Lottery Fund, UK, that aims to reduce the vulnerability of key mobile populations to HIV/AIDS along mobility routes between Bangladesh/India and Nepal/India. The program will deliver interventions at source, transit, and destination points and generate evidence to influence regional policies relating to safe mobility. Key objectives include demonstrating effective models for HIV prevention, care, and support for mobile populations and enhancing partners' capacity. The program will work in source areas in Nepal and Bangladesh, transit areas along the borders, and destination areas in major Indian cities. Initial activities include mapping populations, stakeholder analyses, and building common understanding among partners.
Emphasis pres-sep 1-2010-12nb
The document summarizes the EMPHASIS (Enhancing Mobile Populations’ Access to HIV & AIDS Services, Information, and Support) program, a 5-year initiative funded by the Big Lottery Fund, UK. The program aims to reduce vulnerability to HIV/AIDS among mobile populations in Bangladesh, India, and Nepal. Key activities include testing cross-border service models, building knowledge about mobile populations, building partner capacity, and influencing policies. The program works along the Nepal-India and Bangladesh-India borders at source, transit, and destination points.
Emphasis pres-sep 1-2010-12
The EMPHASIS program aims to reduce vulnerability to HIV/AIDS among mobile populations in Bangladesh, India, and Nepal. It will deliver targeted interventions along two mobility routes: Bangladesh/India and Nepal/India. The first year will focus on building knowledge about mobile populations and their vulnerabilities. Key processes so far include staff recruitment, workshops to develop a common understanding among partners, and contracting five NGO partners to deliver services and conduct mapping exercises in source, transit, and destination areas along the mobility routes.
Emphasis pres-apr-9th-2010-11
The EMPHASIS program aims to reduce vulnerability to HIV/AIDS among mobile populations in Bangladesh, India, and Nepal through focused interventions. It is a 5-year initiative funded by the Big Lottery Fund of the UK. The program will work along two mobility routes - Bangladesh/India and Nepal/India - at source, transit, and destination points to deliver services and influence policies related to safe mobility. Initial activities have included staff recruitment, partner selection, mapping exercises to understand population flows and vulnerabilities, and overcoming communication challenges across countries. Estimates indicate around 100,000 Nepalis cross into India annually through targeted transit points, with around 11,000 going to Delhi and 8,500 to Mumbai.
Emphasis pres-apr-9th-2010-1
The document provides an overview of the EMPHASIS program, which aims to reduce vulnerability to HIV/AIDS among mobile populations in Bangladesh, India, and Nepal. It discusses the high levels of mobility between the countries due to factors like poverty and economic opportunities. This mobility increases vulnerability to HIV through risks like unsafe sex, exploitation, and lack of access to services. The program will deliver interventions along key mobility routes and influence policies. It will work in source, transit, and destination areas and partner with NGOs. Initial activities included staff recruitment, workshops to build common understanding, and NGO partner contracting and mapping activities.
Emphasis
The document summarizes the EMPHASIS project, a regional project run by CARE India across India, Nepal, and Bangladesh aimed at enhancing mobile populations' access to HIV/AIDS information and services. It will take a source-transit-destination link model approach over five years starting in August 2009, providing services across the mobility continuum. Key activities include mapping mobile populations, developing communication tools like an online platform, and administering finances and partnerships with sub-grantees across the three countries.
Emphasis steering committee
The document provides an update on the EMPHASIS program for a steering committee. It summarizes activities in the first year, including staff recruitment, workshops to build common understanding, mapping activities with NGO partners, and snapshots from field visits. Key processes included establishing common understanding across countries, contracting NGO partners, and overcoming communication divides. Financial status and milestones for the first year in India are also outlined. The discussion section proposes including partner program representatives, establishing source-transit-destination agreements, ensuring regionalism through sharing, and addressing concerns about the neutrality of the secretariat location.
Emphasis km process
The document outlines different knowledge management processes including communication methods like chat, discussion forums, blogs, and group work. It also includes summarizing discussions, consolidating replies, and creating collaborative documents, reports, guidelines and budgets. Knowledge assets and resources such as documents, websites and organizations are organized into archives.
Emphasis km dream
The document provides excerpts from various religious texts that discuss themes of light, knowledge, and moving from darkness to light or ignorance to enlightenment. The excerpts are from Christian, Islamic, Hindu, Buddhist, and Sikh scriptures and texts. They discuss concepts like seeking knowledge and enlightenment, following the path of righteousness, and God or divine figures guiding believers from darkness to light.
More from Mohamed Rafique (20)
Final presentation for bangladesh annual review meeting
Final presentation for bangladesh annual review meeting
Recently uploaded
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
It includes regulation of combination products and medical devices. FDA and industry liaisons.
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Learn about body grief and ways to cope with it. We will also explore methods to heal from this challenging experience.
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Study Guide Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Course Hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Answers Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Course hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Study Guide Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Ebook Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Questions Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Stuvia
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Efficacy of Avartana Sneha in Ayurveda
Avartana Sneha is a unique method of Preparation of Sneha Kalpana in Ayurveda, mainly it is indicated for the Vataja rogas.
Recently uploaded (20)
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Wesat2003
- 1. Stratall ANRS 12110 / ESTHER trial A randomised trial comparing a public-health approach to a standard clinical approach in delivering antiretroviral therapy C. Kouanfack, C. Laurent, G. Laborde-Balen, A. F. Aghokeng, A. Bourgeois, S. Kazé, J-M. Mben, M. Dontsop, E. Mpoudi-Ngolé, S. Koulla-Shiro, E. Delaporte for the Stratall ANRS 12110 / ESTHER Study Group.
- 2. Antiretroviral therapy coverage in low- and middle-income countries, December 2007 31% [27–34%] 9 700 000 [8.7–11.0 million] 2 990 000 [2.7–3.3 million] Total 7% 100 000 7 000 North Africa and the Middle East 17% 320 000 54 000 Europe and Central Asia 25% 1 700 000 420 000 East, South and South-East Asia 62% 630 000 390 000 Latin America and the Caribbean 30% 7 000 000 2 120 000 Sub-Saharan Africa Coverage Estimated need Number of people receiving ARV therapy Geographical Region
- 13. Baseline characteristics of patients (n=459) Women 70.6% Median age (IQR) 36.9 (30.2-44.8) WHO clinical stage 2 3 4 0.2% 73.2% 26.6% Median CD4 cell count (IQR) 181 (87-336) Median HIV-1 RNA level (IQR) 5.6 (5.1-6.0)
- 14. Survival 0.00 0.25 0.50 0.75 1.00 0 90 180 270 360 Days
- 15. Deaths or stage 3 or 4 events 0.00 0.25 0.50 0.75 1.00 0 90 180 270 360 Days
- 16. ART change 0.00 0.25 0.50 0.75 1.00 0 90 180 270 360 Days
- 20. Thank you for your kind attention